Evolve Ltd. to distribute VarSome Clinical in Malta

Posted by Tomas Kucera on Feb 4, 2020 5:31:16 PM

Lausanne, Switzerland - February 4, 2020 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with Evolve Ltd., a leading distributor providing innovative solutions such as Illumina etc. Saphetor’s VarSome Clinical, a clinically certified platform for interpretation of NGS data extends Evolve’s portfolio of tools and services for a wide range of its clients employing NGS technologies for clinical as well as for research purposes.

Danyel Biotech to distribute VarSome Clinical in Israel

Posted by Tomas Kucera on Jan 16, 2020 11:00:00 AM

Lausanne, Switzerland - January 16, 2020 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with Danyel Biotech, a leading distributor providing innovative solutions such as Illumina, ArcherDx etc. Saphetor’s VarSome Clinical, a clinically-certified platform for interpretation of NGS data extends Shiva’s portfolio of tools and services for a wide range of its clients employing NGS technologies for clinical as well as for research purposes.

Shiva Scientific to distribute VarSome Clinical in India

Posted by Tomas Kucera on Jan 13, 2020 5:21:12 PM

Lausanne, Switzerland - January 13, 2020 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with Shiva Scientific Company, a leading distributor providing innovative solutions in the field of Genomics and Transplantation. Saphetor’s VarSome Clinical, a clinically-certified platform for interpretation of NGS data extends Shiva’s portfolio of tools and services for a wide range of its clients employing NGS technologies for clinical as well as for research purposes.

Saphetor SA and 4bases announce partnership to accelerate data interpretation for targeted NGS panels

Posted by Tomas Kucera on Dec 3, 2019 10:00:00 AM

Lausanne, December 3st, 2019. Saphetor SA, a Swiss precision medicine company and the creator of VarSome, a suite of bioinformatics solutions, announced today a partnership with 4bases SA, a Swiss-based company specialized in the development, production, and commercialization of reagent kits and gene assays for clinical NGS.

Varelas to distribute VarSome Clinical in Greece

Posted by Tomas Kucera on Oct 3, 2019 4:28:35 PM

Lausanne, Switzerland - October 3, 2019 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with Varelas, a distributor for clinical applications in Greece. Saphetor’s VarSome Clinical, a clinically-certified platform for interpretation of NGS data extends Varelas’s portfolio of tools and services for a wide range of its clients employing NGS technologies for clinical as well as for research purposes.

Immuno Diagnostic Oy to distribute VarSome Clinical in Finland

Posted by Tomas Kucera on Sep 18, 2019 7:17:52 AM

Lausanne, Switzerland - September 18, 2019 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with Immuno Diagnostic Oy, an authorized distributor in Finland for clinical applications in Finland. Saphetor’s VarSome Clinical, a clinically-certified platform for interpretation of NGS data extends Immuno Diagnostic’s portfolio of tools and services for a wide range of its clients employing NGS technologies for clinical as well as for research purposes.